We tested two human AML cell lines, OCI-AML2 and OCI-AML3, derived from male patients aged 65 and 57 years, both BCOR wildtype (cellmodelpassports.sanger.ac.uk). This evidence concerns the gene BCOR and acute myeloid leukemia.